FOURTH AMENDMENT TO CLINICAL CHEMISTRY ANALYZER AGREEMENTClinical Chemistry Analyzer Agreement • May 6th, 2021 • Heska Corp • In vitro & in vivo diagnostic substances
This Fourth Amendment to Clinical Chemistry Analyzer Agreement (the “Amendment”), entered into as of February 18, 2021 between Heska Corporation (“Heska”) and FUJIFILM Medical Systems U.S.A., Inc. (“FMSU”), modifies the Clinical Chemistry Analyzer Agreement dated January 30, 2007 (“CCAA”), including its amendments by the First Amendment to Clinical Chemistry Analyzer Agreement dated April 1st, 2014, the Second Amendment to Clinical Chemistry Analyzer Agreement dated April 1st, 2015, and the Third Amendment to Clinical Chemistry Analyzer Agreement dated August 27th, 2019. Capitalized terms not otherwise defined have the meanings ascribed to them in the Original Agreement. In the event of any conflict between the terms and conditions of the Original Agreement and this Amendment, the terms and conditions of this Amendment shall control. The headings in this Amendment are included for purposes of convenience only and shall not affect the construction or interpretation of its provisions.
SECOND AMENDMENT TO CLINICAL CHEMISTRY ANALYZER AGREEMENTClinical Chemistry Analyzer Agreement • May 14th, 2015 • Heska Corp • Biological products, (no disgnostic substances)
This Second Amendment to Clinical Chemistry Analyzer Agreement (the "Amendment"), entered into as of April 1st, 2015 (the "Amendment Effective Date") modifies that certain Clinical Chemistry Analyzer Agreement between FUJIFILM Corporation and Heska Corporation, dated January 30, 2007, including its amendments by the First Amendment to Clinical Chemistry Analyzer Agreement dated March 1st, 2014 (collectively "Original Agreement"). Capitalized terms not otherwise defined have the meanings ascribed to them in the Original Agreement. In the event of any conflict between the terms and conditions of the Original Agreement and this Amendment, the terms and conditions of this Amendment shall control. The headings in this Amendment are included for purposes of convenience only and shall not affect the construction or interpretation of its provisions.
CLINICAL CHEMISTRY ANALYZER AGREEMENTClinical Chemistry Analyzer Agreement • March 3rd, 2008 • Heska Corp • Biological products, (no disgnostic substances)
THIS CLINICAL CHEMISTRY ANALYZER AGREEMENT (this “Agreement”) is entered into as of January 30, 2007 (the “Effective Date”) by and between FUJIFILM Corporation., a Japanese corporation having its principal place of business at 26-30, Nishiazabu 2-chome, Minato-ku, Tokyo 106-8620 Japan (“Fuji”) and Heska Corporation, a Delaware corporation, having its principal place of business at 3760 Rocky Mountain Avenue, Loveland, CO 80538, USA (“Heska”).
THIRD AMENDMENT TO CLINICAL CHEMISTRY ANALYZER AGREEMENTClinical Chemistry Analyzer Agreement • February 28th, 2020 • Heska Corp • In vitro & in vivo diagnostic substances
This Third Amendment to Clinical Chemistry Analyzer Agreement (the “Amendment”), entered into as of August 27th, 2019, modifies that certain Clinical Chemistry Analyzer Agreement between FUJIFILM Corporation and Heska Corporation, dated January 30, 2007, including its amendments by the First Amendment to Clinical Chemistry Analyzer Agreement dated April 1st, 2014 and the Second Amendment to Clinical Chemistry Analyzer Agreement dated April 1st, 2015 (collectively, “Original Agreement”). Capitalized terms not otherwise defined have the meanings ascribed to them in the Original Agreement. In the event of any conflict between the terms and conditions of the Original Agreement and this Amendment, the terms and conditions of this Amendment shall control. The headings in this Amendment are included for purposes of convenience only and shall not affect the construction or interpretation of its provisions.
CLINICAL CHEMISTRY ANALYZER AGREEMENTClinical Chemistry Analyzer Agreement • August 5th, 2014 • Heska Corp • Biological products, (no disgnostic substances)
This First Amendment to Clinical Chemistry Analyzer Agreement (the "Amendment"), entered into as of April 1st, 2014 (the "Amendment Effective Date") modifies that certain Clinical Chemistry Analyzer Agreement between FUJIFILM Corporation and Heska Corporation, dated January 30, 2007 (''Original Agreement"). The Original Agreement, as amended by this Amendment, shall hereinafter be referred to as the "Agreement". Capitalized terms not otherwise defined have the meanings ascribed to them in the Original Agreement. In the event of any conflict between the terms and conditions of the Original Agreement and this Amendment, the terms and conditions of this Amendment shall control. The headings in this Amendment are included for purposes of convenience only and shall not affect the construction or interpretation of its provisions.
